U.S. Physical Therapy, Inc.
USPH
$73.85
-$0.09-0.12%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 623.05M | 598.53M | 574.89M | 553.64M | 535.31M |
| Total Other Revenue | 127.90M | 123.68M | 117.43M | 110.79M | 103.76M |
| Total Revenue | 750.95M | 722.20M | 692.33M | 664.43M | 639.06M |
| Cost of Revenue | 573.72M | 550.57M | 529.33M | 505.87M | 485.63M |
| Gross Profit | 177.23M | 171.63M | 163.00M | 158.56M | 153.43M |
| SG&A Expenses | 66.71M | 63.68M | 60.45M | 58.29M | 56.62M |
| Depreciation & Amortization | 34.63M | 33.29M | 31.85M | 30.20M | 27.30M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 675.05M | 647.54M | 621.63M | 594.35M | 569.56M |
| Operating Income | 75.90M | 74.66M | 70.70M | 70.08M | 69.51M |
| Income Before Tax | 81.18M | 70.64M | 62.78M | 60.21M | 41.99M |
| Income Tax Expenses | 19.85M | 17.18M | 15.33M | 14.61M | 10.18M |
| Earnings from Continuing Operations | 61.32 | 53.46 | 47.45 | 45.60 | 31.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.65M | -15.30M | -14.17M | -14.18M | -8.98M |
| Net Income | 44.67M | 38.16M | 33.28M | 31.42M | 22.84M |
| EBIT | 75.90M | 74.66M | 70.70M | 70.08M | 69.51M |
| EBITDA | 99.34M | 96.66M | 91.15M | 88.76M | 86.62M |
| EPS Basic | 2.38 | 2.29 | 2.17 | 1.84 | 0.93 |
| Normalized Basic EPS | 1.69 | 1.81 | 1.79 | 1.85 | 2.35 |
| EPS Diluted | 2.38 | 2.29 | 2.17 | 1.84 | 0.93 |
| Normalized Diluted EPS | 1.69 | 1.81 | 1.79 | 1.85 | 2.35 |
| Average Basic Shares Outstanding | 60.62M | 60.50M | 60.37M | 60.26M | 60.15M |
| Average Diluted Shares Outstanding | 60.62M | 60.50M | 60.37M | 60.26M | 60.15M |
| Dividend Per Share | 1.79 | 1.78 | 1.77 | 1.76 | 1.75 |
| Payout Ratio | 60.80% | 70.63% | 79.75% | 84.46% | 115.36% |